©The Author(s) 2019.
World J Gastroenterol. Jan 14, 2019; 25(2): 205-219
Published online Jan 14, 2019. doi: 10.3748/wjg.v25.i2.205
Published online Jan 14, 2019. doi: 10.3748/wjg.v25.i2.205
Table 1 Characteristics of the patients after pancreatoduodenectomy for pancreatic cancer n (%)
| Variable | No. of cases (n = 61) |
| Gender | |
| Male | 26 (42.6) |
| Female | 35 (57.4) |
| Age, yr (median) | 68 |
| T stage | |
| T1 | 3 (4.9) |
| T2 | 3 (4.9) |
| T3 | 55 (90.2) |
| T4 | 0 (0) |
| N status | |
| N0 | 11 (18.0) |
| N1 | 50 (82.0) |
| Lymphatic invasion | |
| L0 | 11 (18.0) |
| L1 | 50 (82.0) |
| Microvascular invasion | |
| V0 | 12 (19.7) |
| V1 | 49 (80.3) |
| Perineural invasion | |
| No | 9 (14.8) |
| Yes | 52 (85.2) |
| Differentiation grade | |
| G1 | 9 (14.8) |
| G2 | 35 (57.4) |
| G3 | 16 (26.2) |
| G4 | 1 (1.6) |
| Resection status | |
| R0 | 56 (91.8) |
| R1 | 5 (8.2) |
| Median survival (mo) | 23.10 |
- Citation: Lukosiute-Urboniene A, Jasukaitiene A, Silkuniene G, Barauskas V, Gulbinas A, Dambrauskas Z. Human antigen R mediated post-transcriptional regulation of inhibitors of apoptosis proteins in pancreatic cancer. World J Gastroenterol 2019; 25(2): 205-219
- URL: https://www.wjgnet.com/1007-9327/full/v25/i2/205.htm
- DOI: https://dx.doi.org/10.3748/wjg.v25.i2.205